logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
H

Haiping Dai

Soochow University

21H指数
175论文数
1.9K被引数
收录论文 63
发表时间
logo
Quantification of isavuconazole in dried blood spots by LC-MS/MS and clinical application for therapeutic drug monitoring通过LC-MS/MS法测定干血斑中伊曲康唑的定量及其在治疗药物监测中的临床应用
errJournal of Pharmaceutical and Biomedical Analysis
IF3.1
err2026-09-29
err0
PREAI
errLiu, Xiaoxue; Liu, Fangfang; Dai, Haiping; Tang, Fang; Liu, Linsheng; Gao, Jie; Chen, Jia; Qu, Qi; Xue, Mengxing; Zhou, Haixia; Cai, Wenzhi; Liu, Yin; Xie, Yan; Huang, Chenrong; Xu, Yang; Miao, Liyan
err分享
err收藏
BiRD Regimen Followed by Anti-BCMA CAR-T Cell Immunotherapy as First-Line Therapy for Newly Diagnosed Multiple Myeloma: A Prospective, Single-Arm, Phase 2 TrialBiRD方案联合抗BCMA CAR-T细胞免疫疗法作为新诊断多发性骨髓瘤的一线治疗：一项前瞻性、单臂、II期临床试验
errAmerican Journal of Hematology
IF9.9
err2026-08-26
err0
errOAAI
errYue Zhou; Juan Chen; Qingya Cui; Haiping Dai; Zheng Li; Jia Yin; Wei Cui; Mengyun Li; Xuekai Li; Xin Zhang; Feiran Gong; Xiaming Zhu; Liqing Kang; Lei Yu; Depei Wu; Xiaowen Tang
err分享
err收藏
Therapeutic Advances in Adult B-cell Acute Lymphoblastic Leukemia with KMT2A Rearrangements成人KMT2A重排B细胞急性淋巴细胞白血病的治疗进展
errAnnals of Hematology
IF2.4
err2026-07-24
err0
errOAAI
errShen-Hao Liu; Ai-Ni Deng; Hui-Ying Li; Kai-Wen Tan; Sheng-Li Xue; Hai-Ping Dai
err分享
err收藏
IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasmsIKZF1N159S与骨髓增生异常性肿瘤患者的预后不良相关
errLeukemia
IF13.4
err2026-07-14
err0
PREAI
errYan Yu; Hongjie Shen; Jundan Xie; Airui Jiang; Tongtong Zhang; Yi Xu; Qian Wang; Haiping Dai; Zixuan Ding; Liang Ma; Man Wang; Jingjing Xu; Yali Zhou; Aining Sun; Depei Wu; Zixin Chen; Suning Chen; Hong Yao
err分享
err收藏
Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study新诊断急性髓系白血病中具有高风险早期死亡特征的急粒单细胞白血病样亚组的临床与分子综合特征：一项多中心研究
errHaematologica
IF7.9
err2026-05-01
err0
PREAI
errShu, Mingkai; Ding, Wenjing; Wang, Linlin; Wang, Zheng; Wang, Lijun; Zhu, Mingqing; Liu, Dandan; Shen, Hongjie; Wang, Yun; Dou, Xueqing; Ma, Xiao; Zhang, Yang; Xu, Yang; Wang, Ying; Xue, Shengli; Fu, Jianhong; Qiu, Huiying; Tang, Xiaowen; Han, Yue; Huang, Jinyan; Wu, Depei; Dai, Haiping; Wen, Lijun; Chen, Suning
err分享
err收藏
New selective and allosteric FLT3 inhibitors show efficacy against resistant acute myeloid leukemia cells新型选择性及别构FLT3抑制剂对耐药急性髓系白血病细胞显示出疗效
erriScience
IF4.1
err2026-03-03
err0
errOAAI
errShuai-Shuai Ge; Qiao-Cheng Qiu; Jingsheng Hua; Jun Wang; Minfeng Yang; Jiahui Du; Yuan-Hong Huang; Chao-Ling Wan; Ling-Ling Liu; Hai-Ping Dai; Maofeng Zhang; Binghui Shen; Sheng-Li Xue; Fang Chen; Song-Bai Liu
err分享
err收藏
Donor-derived and patient-derived IL-6 knock-down CAR T-19 exhibit similar efficacy and safety in treating relapsed B-cell acute lymphoblastic leukemia patients after allo-HSCT供者来源和患者来源的IL-6敲低CAR T-19在治疗异基因造血干细胞移植后复发的B细胞急性淋巴细胞白血病患者方面表现出相似的疗效和安全性。
errCytotherapy
IF3.2
err2026-02-16
err0
PREAI
errTing Sun; Jin-Feng Ma; Xu Jia; Shun-Zhe Xu; Shen-Hao Liu; Xiao-Yu Lyu; Si-Man Huang; Yan-Jun Wu; Zhen Yao; Chong-Sheng Qian; Zheng Li; Lei Yu; Hai-Ping Dai; Wen-Jie Gong; Sheng-Li Xue
err分享
err收藏
Coexistence of BCR::ABL1 with IKZF1::ETV6 fusion in an adult patient with acute B-lymphoblastic leukemiaBCR::ABL1与IKZF1::ETV6融合在一名成人急性B淋巴细胞白血病患者中的共存
errLEUKEMIA & LYMPHOMA
IF2.2
err2026-02-01
err0
PREAI
errTan, Kai-Wen; Xu, Yi; Huang, Yuan-Hong; Qiu, Qiao-Cheng; Lyu, Xiao-Yu; Huang, Si-Man; Wang, Zi-Hao; Li, Hui-Ying; Xu, Shun-Zhe; Liu, Fang-Tong; Liu, Shen-Hao; Zhang, Yang; Xue, Sheng-Li; Dai, Hai-Ping
err分享
err收藏
Treatment outcome and efficacy of desensitization strategies for immunized-PTR in hematological malignancies before hematopoietic stem cell transplantation
errBone Marrow Transplantation
IF5.2
err2026-01-28
err0
PREAI
errYizhou Pan; Yuanling Zuo; Qingya Cui; Sining Liu; Haiping Dai; Depei Wu; Min Jiang; Xiaowen Tang
err分享
err收藏
Regulated expression of miR-99a and miR-100 relates clinical and prognostic parameters of acute myeloid leukemiamiR-99a和miR-100的调控表达与急性髓系白血病的临床和预后参数相关
errHematology
IF1.6
err2025-12-31
err0
PREAI
errDing, Chao; Dai, Haiping; Ren, Xiaolei; Wang, Chenlong; Ning, Jun; Gong, Hao
err分享
err收藏
Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial维奈克拉联合阿扎胞苷治疗复发或难治性T细胞急性淋巴细胞白血病：一项多中心、单臂、II期试验
errThe Lancet Haematology
IF0
err2025-12-01
err0
PREAI
errHan-Yu Cao; Hao Zhang; Yang Zhang; Xiao-Hui Hu; Li Yang; Yan-Li Yang; Yan-Ming Zhang; Bing Wu; Zhen-Qi Huang; Rui Huang; Rui-Juan Wang; Chao-Ling Wan; De-Pei Wu; Hai-Ping Dai; Sheng-Li Xue
err分享
err收藏
A phase 2 trial of a “sandwich” strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Philadelphia chromosome–negative B-cell acute lymphoblastic leukemia一项“夹心”策略的2期临床试验：序贯CD22/CD19嵌合抗原受体T细胞疗法联合自体造血干细胞移植治疗费城染色体阴性B细胞急性淋巴细胞白血病患者
errCancer
IF5.1
err2025-11-06
err0
errOAAI
errChong-Sheng Qian MD, PhD; Zi-Hao Wang MS; Zheng Li MD, PhD; Zhen Yao MD; Wen-Jie Gong MD, PhD; Yan-Jun Wu MS; Hai-Xia Zhou MD; Ming-Zhu Xu MD; Yan Qiu MS; Shun-Zhe Xu MS; Kai-Wen Tan MS; Fang-Tong Liu MS; Si-Man Huang MS; Han-Yu Cao MD; Hai-Ping Dai MD, PhD; De-Pei Wu MD, PhD; Sheng-Li Xue MD, PhD
err分享
err收藏
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trialIL-6基因敲低抗CD19 CAR-T细胞（ssCART-19）用于复发或难治性急性淋巴细胞白血病患者的I期临床试验
errBlood Cancer Journal
IF11.6
err2025-10-27
err0
errOAAI
errSheng-Li Xue; Mei-Jing Liu; Chong-Sheng Qian; Su-Ning Chen; Hui-Ying Qiu; Li-Qing Kang; Hai-Ping Dai; Wen-Jie Gong; Li-Yun Chen; Zhen Yao; Ming-Zhu Xu; Hai-Xia Zhou; Xiao-Fei Yang; Qian Wu; Xue-Qing Dou; Jian Zhang; Yin Liu; Qing-Ya Cui; Zheng Li; Yang Xu; Man Qiao; Tong-Tong Zhang; Jing-Wen Tan; Nan Xu; Ming-Hao Li; Zhou Yu; Xiao-Yan Lou; Wei Wang; Hong-Jia Zhu; Lu Qin; Lei Yu; Xiao-Wen Tang; De-Pei Wu
err分享
err收藏
Phase II study of dual epigenetic targeting with chidamide and azacitidine in patients with high-risk acute myeloid leukemia after allo-HSCT使用沙利度胺和氮杂胞苷对allo-HSCT后高危急性髓系白血病患者的双重表观遗传靶向治疗的II期研究
errClinical Epigenetics
IF4.4
err2025-10-14
err0
errOAAI
errYa-Xue Wu; Chao-Ling Wan; Kai-Wen Tan; Yang Zhang; Yan-Ming Zhang; Hao Zhang; De-Pei Wu; Su-Ning Chen; Ying Wang; Xiao Ma; Hai-Ping Dai; Chong-Sheng Qian; Shan-Shan Jiang; Hai-Yan Bao; Xiao-Hui Hu; Zheng Li; Sheng-Li Xue
err分享
err收藏
Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysis维奈克拉联合去甲基化药物对比启动方案作为伴骨髓增生异常相关改变的新诊断急性髓系白血病的初始治疗：一项倾向性评分匹配分析
errLEUKEMIA & LYMPHOMA
IF2.2
err2025-10-01
err0
PREAI
errHuang, Yuan-Hong; Liu, Fang-Tong; Wan, Chao-Ling; Wang, Zi-Jin; Liu, Yu-Qing; Cao, Han-Yu; Huang, Si-Man; Tan, Kai-Wen; Ge, Shuai-Shuai; Wang, Miao; Liu, Mei-Jing; Wang, Zi-Hao; Lyu, Xiao-Yu; Dai, Hai-Ping; Li, Zheng; Xue, Sheng-Li
err分享
err收藏
Adult AML with NUP98 rearrangements should be stratified into adverse-risk group携带NUP98重排的成人急性髓系白血病（AML）应归为不良风险组。
errBlood Cancer Journal
IF11.6
err2025-07-02
err0
errOAAI
errWusixian Huang; Man Wang; Jundan Xie; Qian Wang; Haiping Dai; Suning Chen; Qinrong Wang
err分享
err收藏
CD19 CAR-T in relapsed t(8;21) AML: a single-center prospective phase II clinical trialCD19 CAR-T在复发t(8;21) AML中的应用：一项单中心前瞻性II期临床试验
errJOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
err2025-05-06
err0
errOAAI
errYin, Jia; Cui, Qing-Ya; Dai, Hai-Ping; Qu, Chang-Ju; Li, Zheng; Kang, Li-Qing; Cui, Wei; Tian, Xiao-Peng; Zhu, Xia-Ming; Yu, Lei; Wu, De-Pei
err分享
err收藏
Comparative Analysis of Treatment Effects of Different Materials on Thin Oil Films不同材料对薄油膜处理效果的比较分析
errMATERIALS
IF3.2
err2025-03-26
err0
errOAAI
errWu, Xiuli; Zheng, Bo; Dai, Haiping; Ke, Yongwen; Cai, Cheng
err分享
err收藏
Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD降低剂量化疗后使用blinatumomab治疗新诊断的费城染色体阴性B细胞前体急性淋巴细胞白血病：与hyper-CVAD的倾向评分匹配比较
errDISCOVER ONCOLOGY
IF2.9
err2025-02-21
err0
errOAAI
errLu, Jing; Zhu, Yu; Qiu, Huiying; Wang, Ying; Zhou, Xin; Dai, Haiping; Lu, Xuzhang; Gu, Bin; Hong, Ming; Miao, Miao; Lu, Ruinan; Wang, Jun; Wu, Qian; Xue, Mengxing; Wang, Yun; Deng, Ailing; Shen, Yaoyao; Liu, Yin; Dou, Xueqing; Lei, Yutian; Yang, Xiaofei; Chen, Suning
err分享
err收藏
Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute lymphoblastic leukemia/lymphomaCar-t细胞治疗急性T淋巴细胞白血病/淋巴瘤的临床疗效和安全性
errANNALS OF HEMATOLOGY
IF2.4
err2024-12-18
err0
PREAI
errMa, Jin-Feng; Yan, Chun-Long; Jia, Xu; Zhu, Hong-Jia; Yan, Jia-Wei; Liu, Mei-Jing; Zhang, Dai-Yi; Liu, Shen-Hao; Xu, Nan; Zhang, Hai-Guo; Ye, Ling; Yu, Lei; Wu, De-Pei; Gong, Wen-Jie; Dai, Hai-Ping; Xue, Sheng-Li
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
刘泓 封面图
刘泓 (Hong Liu)
H 指数: 135 · 论文数: 2.8K
张扬 封面图
张扬 (Yang Zhang)
H 指数: 112 · 论文数: 1.6K
王
王颖 (Ying Wang)
H 指数: 105 · 论文数: 1.5K
张建 封面图
张建 (Jian Zhang)
H 指数: 98 · 论文数: 2.2K
陈
陈灰 (Hui Chen)
H 指数: 96 · 论文数: 2.2K
查看更多